CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed· 60 enrolled
Drug / intervention
Teriparatide +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01225055
NCT01225055Phase 2Completed
CompareCT.gov

Effect of Teriparatide, Vibration and the Combination on Bone Mass and Bone Architecture in Chronic Spinal Cord Injury

Thomas J. Schnitzer·interventional·Posted Oct 20, 2010·Updated Dec 2, 2025

In Brief

A Phase 2 clinical trial evaluating Teriparatide and vibration for Spinal Cord Injury and 2 related conditions. Completed, enrolled 60 participants across 2 sites.

Detailed Summary

Spinal cord injury (SCI) results in marked acute loss of bone. This study evaluates the effect of teriparatide (PTH) and the use of vibration as a form of mechanical stimulation on bone mass.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsSpinal Cord Injury, Bone Loss, Osteoporosis
CountriesUnited States
CollaboratorsEdward Hines Jr. VA Hospital, University of Illinois at Chicago, Congressionally Directed Medical Research Programs

Timeline

Phase 2CompletedFinished
2011201220132014201520162017201820192020202120222023202420252026
First PostedOct 20, 2010
Enrollment StartOct 1, 2010
Primary CompletionAug 1, 2015
Study CompletionAug 1, 2016
TodayJul 2, 2026
Enrollment to primary: 4.8 yearsPosted 15.7 years ago

Interventions

Teriparatidedrug

20 ug daily over 12 months

vibrationdevice

10 min/day for 12 months